Study late effects after sickle cell curative treatments
Part of Blood & lymphatic, Genetic & congenital, Heart & circulation, Kidney & urinary, Lungs & breathing, Women’s health & pregnancy clinical trials.
This study looks at long-term health effects after curative treatments for sickle cell disease, such as bone marrow transplant. Your participation helps researchers understand what changes over time after treatment, and what might need monitoring or care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed lab diagnosis of sickle cell disease (SCD)
- You can understand the study and sign consent
- You can share health information before and after your curative treatment
- You have already had either a stem cell transplant (HSCT) or standard disease-modifying therapy
- You do not have a history of not following through with study visits or study requirements
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps connect adults with sickle cell disease who haven't seen a specialist in over a year back into care. It tests a program designed to make it easier to get regular medical support and improve your health.
This study tests whether a long-term endurance exercise program can improve physical fitness, reduce complications, and enhance quality of life for people with sickle cell disease. It is designed for patients whose condition is stable but who have had at least one pain crisis in the last three years.
This study compares the health status and quality of life of people with sickle cell disease who had a stem cell transplant from a brother or sister, between 2000 and 2012, with people who did not have the transplant. The goal is to understand how the transplant affects long-term well-being.
This early-phase study tests whether a “half-matched” donor bone marrow transplant, with special medicines to calm the immune system before transplant, can improve outcomes for people with sickle cell disease. It may help high-risk patients who have frequent complications and don’t have a fully matched donor.
This trial tests an investigational drug called DISC-3405 in people with sickle cell disease (SCD) to see if it is safe and how it affects your body. It may be an option if you have certain SCD complications or lab results.
This trial tests a new treatment called CS-206 for adolescents with severe sickle cell disease. It aims to see if this treatment can help by making stem cell transplants safer and more effective for people who have not done well with standard care.
Hear when a new Sickle Cell Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.